Growth Metrics

Allurion Technologies (ALURW) Current Leases (2022 - 2026)

Allurion Technologies posted quarterly Current Leases of $441000.0 for Q1 2026, down 46.8% year-on-year from $829000.0 in Q1 2025, and up 10.8% on a QoQ basis from $398000.0 in Q4 2025.

Allurion Technologies (ALURW) has 5 years of Current Leases data on file, last reported at $441000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases fell 46.8% year-over-year to $441000.0; the trailing twelve-month figure through Mar 2026 stood at $441000.0 (down 46.8% YoY), and the FY2025 full-year result was $398000.0, down 54.2% from the prior year.
  • Current Leases for Q1 2026 stood at $441000.0, up from $398000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $908000.0 in Q4 2023 and bottomed at $398000.0 in Q4 2025.
  • The 5-year median for Current Leases is $829000.0 (2025), against an average of $712769.2.
  • Peak annual rise in Current Leases reached 1.84% in 2025, while the deepest fall reached 54.2% in 2025.
  • A 5-year view of Current Leases shows it stood at $905000.0 in 2022, then advanced by 0.33% to $908000.0 in 2023, then retreated by 4.3% to $869000.0 in 2024, then tumbled by 54.2% to $398000.0 in 2025, then increased by 10.8% to $441000.0 in 2026.
  • The last three Current Leases figures came in at $441000.0 (Q1 2026), $398000.0 (Q4 2025), and $471000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 Allurion Technologies - - 1.23 Mn 441,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 441,000.00
Dec 31, 2025 398,000.00
Sep 30, 2025 471,000.00
Jun 30, 2025 597,000.00
Mar 31, 2025 829,000.00
Dec 31, 2024 869,000.00
Sep 30, 2024 471,000.00
Jun 30, 2024 850,000.00
Mar 31, 2024 814,000.00
Dec 31, 2023 908,000.00
Sep 30, 2023 873,000.00
Jun 30, 2023 840,000.00
Dec 31, 2022 905,000.00